Polyclonal Rabbit anti-Human SLC5A11 / SMIT2 Antibody (WB)
Catalog Number: LS-C748223
2 sizes / from $281.00
Antibody: Rabbit Polyclonal
Applications: Immunohistochemistry (general), Western Blot
Reactivity: Human, Mouse, Rat
Format: Liquid
Polyclonal Rabbit anti-Human SLC6A6 / Taurine Transporter Antibody (IHC)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Flow Cytometry, Immunocytochemistry, Immunohistochemistry (general), Immunohistochemistry, Paraffin |
| Reactivity: | Human |
| Format: | Liquid |
$456.00each
Catalog Number: LS-C179237-50
Catalog Number: LS-C179237
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- Taurine Transporter antibody LS-C179237 is an unconjugated rabbit polyclonal antibody to human Taurine Transporter (SLC6A6). Validated for Flow, ICC and IHC. Cited in 1 publication.
- Application
- FC, ICC, IHC, IHC-P
- Reactivity
- Hu
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- SLC6A6 | TAUT | Taurine transporter
- Recommended Dilution: FC
- 1:200
- Recommended Dilution: IF/ICC
- 1:200
- Recommended Dilution: IHC-P
- 1:5000
- UniProt Number
- P31641
- NCBI GenBank
- NM_003043 | NP_003034.2
- SwissProt
- P31641
Target
- Target
- Human SLC6A6 / Taurine Transporter
- Antigen Species
- Human
- Epitope
- Human Taurine Transporter / SLC6A6
- Gene Name
- SLC6A6
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
- Isotype
- IgG
Immunogen
- Immunogen
- Synthetic peptide derived from human SLC6A6
- Immunogen Type
- Synthetic Peptide (Linear)
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, pH 7.2, 50% Glycerol
- Volume
- 50 Microliter
- Preservative
- No
Storage & Handling
- Storage Conditions
- Store at -20°C for 1 year.
- Recommended Storage Buffer
- PBS
Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AML. Perna F, Berman SH, Soni RK, Mansilla-Soto J, Eyquem J, Hamieh M, Hendrickson RC, Brennan CW, Sadelain M. Cancer cell. 2017 October;32:506-519. PubMed: 29017060
